Regentis Biomaterials Ltd.
RGNTNYSEAMERICANHealthcareMedical Instruments & Supplies
As of Oct 16, 2026 close
- Market cap
- $9.23M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.23$15.50
- Volume (live)
- -
- Avg. volume (3M)
- 54.67K
Regentis Biomaterials (RGNT) Stock Price & Financial Analysis
Regentis Biomaterials Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.46 - $1.60 |
|---|---|
| 52-Week High | $15.50 |
| 52-Week Low | $1.23 |
| Open | $1.60 |
| Volume (last close) | 23.49K |
| Average Volume (3M) | 54.67K |
| 50-Day MA | $1.92 |
|---|---|
| 200-Day MA | $3.24 |
| Market Cap | 9.23M |
|---|---|
| Shares Outstanding | 5.95M |
| Price to Book (P/B) | 1.20 |
| EV/EBITDA | -0.11 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Regentis Biomaterials at a Glance
As of the Oct 16, 2026 close, Regentis Biomaterials (RGNT) has a market capitalization of $9.23M.
As of its latest reported balance sheet, it holds $8.95M in cash and securities against $1.20M of debt, a net cash position of $7.75M.
Regentis Biomaterials does not currently pay a dividend.
At $1.49 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $1.23 to $15.50, below its 200-day moving average of $3.24.
Frequently Asked Questions About Regentis Biomaterials
What is the current stock price for RGNT?
As of the Oct 16, 2026 close, RGNT stock trades at $1.49. The 52-week range is $1.23–$15.50, with a day range of $1.46–$1.60.
What is the P/E ratio for RGNT?
The P/E ratio (Price-to-Earnings) for RGNT is shown in the Key Statistics section. This valuation metric helps compare Regentis Biomaterials Ltd. to industry peers.
Does RGNT pay dividends?
Regentis Biomaterials does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for RGNT?
Analyst ratings and recommendations for RGNT are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of RGNT?
As of the Oct 16, 2026 close, Regentis Biomaterials's market capitalization is $8.9M, classifying it as a micro-cap company. Regentis Biomaterials operates in the Healthcare sector within the Medical Instruments & Supplies industry.